ExploreTreatments
Updated: June 12, 2026 · By Charly P.

Ro vs SHED: FDA-Approved Wegovy Pill vs Compounded Injectable (2026)

Ro's FDA-approved Wegovy Pill starts at $39/month with no injections. SHED offers compounded GLP-1 injections at competitive rates. We compare 12-month costs, medication type, and who each program is realistically built for.

Disclosure: Some links on this page are affiliate links. We may earn a commission if you purchase through them, at no extra cost to you.

Quick Verdict

Editorial Take

Best Overall: Ro - FDA-approved Wegovy Pill with transparent $39 start and clear half-list pricing

Best for Budget: SHED - competitive pricing structure worth checking for current rates

Best for Fast Approval: Ro - get started online for just $39 with no clinic visit needed

At a Glance Comparison

FeatureRoSHED
Starting Price$39 to get startedCompetitive pricing, check current rates
MedicationsWegovy Pill (FDA-approved oral)Compounded GLP-1 medications
Pricing TransparencyHalf list price, clearly statedLess publicly detailed
Medication FormOral pill, no injectionCompounded injectables
Hidden FeesNoneNone stated

Who Should Choose Ro

Choose Ro if:

  • You want the only FDA-approved GLP-1 oral pill with no injections required
  • You value transparent, publicly stated pricing before signing up
  • You want to start for $39 with an established telehealth brand
  • You prefer a large well-known provider with a documented track record
  • You want regulatory certainty of an FDA-approved medication

Who Should Choose SHED

Choose SHED if:

  • You have checked SHED's current pricing and found it competitive for your situation
  • You prefer compounded GLP-1 injectable options
  • You want flexible payment structures with your GLP-1 program
  • You are comfortable with a growing telehealth brand rather than an established one
  • You want to compare compounded pricing against Ro's pill-based model

Ro Deep Dive

Compared to SHED, Ro stands out on two fronts: pricing transparency and regulatory clarity. Ro offers the Wegovy Pill, the first FDA-approved oral GLP-1 weight loss medication, at a clearly stated half the published list price, starting at $39. When evaluating a newer or less transparent provider, having a publicly verifiable price and an FDA-approved product is a practical advantage.

How It Works

  1. Start online for $39, complete a medical questionnaire from any device
  2. A licensed Ro physician reviews your health information and prescribes the Wegovy Pill if appropriate
  3. Oral tablet shipped by mail, no injection, no refrigerated shipping, no self-administration training
  4. Priced at half the published list price with no hidden fees
  5. Ongoing dose management and physician support through the Ro platform

Medications Offered

  • Wegovy Pill, the first FDA-approved oral GLP-1 weight loss medication
  • Oral semaglutide tablet, no weekly injection required
  • Same active ingredient as injectable Wegovy, in pill form

Pricing

Start for $39. Ongoing Wegovy Pill at half the published list price. No hidden fees, no membership charges. Pricing is publicly stated.

Pros
  • FDA-approved medication, not compounded
  • Transparent pricing: half list price, $39 to start
  • No injections, oral pill is simpler and less intimidating
  • Large established telehealth company with documented patient experience
  • No hidden fees or membership costs
Cons
  • No tirzepatide, limited to semaglutide only
  • No 0% financing options publicly advertised
  • Less dosing flexibility than compounded providers

SHED Deep Dive

SHED is a growing telehealth weight loss platform offering compounded GLP-1 medications with competitive pricing, flexible delivery, and no membership fees. Current rates require direct inquiry.

How It Works

  1. Complete an online health assessment and eligibility questionnaire
  2. Medical team reviews your eligibility for GLP-1 treatment
  3. Prescription approval and medication processing
  4. Fast delivery to your door
  5. Flexible payment structures available

Medications Offered

  • Compounded GLP-1 medications
  • Flexible prescription and dose management
  • Multiple medication options, check current offerings

Pricing

SHED offers competitive pricing for compounded GLP-1 medications. Check SHED's website for current rates, published pricing is less detailed than established providers.

Pros
  • Competitive pricing, may undercut larger platforms
  • No membership fees
  • GLP-1 access through licensed physicians
  • Fast delivery options
  • Flexible payment structures
Cons
  • Compounded medications only, no FDA-approved pill option
  • Less publicly available pricing than established competitors
  • Newer brand with less documented patient experience
  • Medication options less transparently listed

Honest Tradeoffs

Pricing

Ro publishes its pricing clearly: $39 to start, Wegovy Pill at half list price, no hidden fees. SHED's pricing is less publicly detailed, you may need to complete intake to get a quote. For consumers who want to compare before committing, Ro's transparency is a real advantage. SHED may offer competitive rates, but verify directly before deciding.

Medication Types

Ro offers the FDA-approved Wegovy Pill, an oral semaglutide tablet that has cleared the FDA approval process. SHED's compounded GLP-1 medications have not gone through the same process. For patients who prioritize regulatory certainty, Ro has the edge. SHED may offer more dosing flexibility at the cost of FDA status.

Doctor Involvement

Both use licensed physicians for prescription review. Ro's telehealth infrastructure is well established. SHED is growing, so depth of ongoing physician support may be less consistent. Both require a medical questionnaire before prescribing.

Delivery Speed

SHED markets fast delivery as a feature. Ro ships oral tablets requiring no temperature handling. SHED's compounded injectables may need temperature-controlled packaging. Both deliver to your door via different logistics.

Subscription Model

Ro operates on a clear half-list-price model, simple and easy to understand. SHED's pricing model is less transparent publicly. Ro wins on simplicity; SHED may win on raw price for some patients, but requires direct verification.

Pricing Breakdown

AspectRoSHED
Get Started$39Contact SHED for current rates
Medication TypeFDA-approved oral pillCompounded injectable
Pricing TransparencyClearly published, half list priceLess publicly detailed
Hidden FeesNoneNone stated
Best ForTransparency + FDA approval seekersCompetitive-rate seekers willing to inquire

Medication Comparison

Semaglutide

Ro: Wegovy Pill, FDA-approved oral semaglutide tablet. SHED: Compounded GLP-1 injectables (formulation details less publicly documented).

Tirzepatide

Ro: Not offered. SHED: GLP-1 options are less specifically listed, confirm with SHED directly.

Which Provider Offers What

Ro provides the FDA-approved Wegovy Pill at half list price with full pricing transparency. SHED provides compounded GLP-1 medications at competitive pricing that requires direct inquiry.

Results Expectations

Both use GLP-1 active ingredients. Semaglutide clinical data shows 10–15% average weight loss over 68 weeks. Results depend on adherence, diet, and activity. Neither provider can guarantee outcomes.

Safety Considerations

Side Effects

GLP-1 medications commonly cause nausea, diarrhea, constipation, and fatigue during dose escalation. Both Ro and SHED provide physician oversight to manage side effects and adjust dosing.

Doctor Supervision

Both require physician review before prescribing. Ro's established infrastructure has documented support processes. SHED as a growing platform may have variability in follow-up support, confirm the level of ongoing contact before enrolling.

Prescription Requirement

Both require a valid prescription from a licensed US physician. Standard GLP-1 contraindications apply. Medical questionnaires screen for disqualifying conditions.

How We Evaluated These Providers

We evaluated both providers based on the following criteria:

  • Pricing transparency: whether costs are publicly stated or require completing a sign-up to access
  • Regulatory status: FDA-approved oral pill (Ro) vs compounded injectable (SHED)
  • Medication form: oral pill vs injection and its impact on patient experience
  • Brand maturity: established telehealth infrastructure (Ro) vs growing platform (SHED)
  • Published medication options: how clearly each provider lists what is available
  • Physician oversight quality: consistency and depth of medical support
  • Hidden fees and membership costs: what is included in the stated price

Final Verdict

Editorial Take

Best for Budget Users

SHED may offer competitive pricing, but requires direct inquiry to confirm. Ro's $39 start with half-list Wegovy Pill pricing is publicly verifiable. Get a SHED quote and compare it against Ro's published pricing before deciding.

Best for Fast Results

Ro's Wegovy Pill is FDA-approved with a documented titration schedule. SHED's compounded medications may allow faster dose customization, but without published formulation details this is hard to assess.

Best for Doctor Supervision

Both require physician review. Ro's larger patient base suggests more consistent support infrastructure. Verify SHED's level of ongoing care before enrolling.

Best Premium Experience

Ro wins on FDA-approval clarity and pricing transparency. If SHED's pricing proves significantly lower after inquiry, it may win for compounded injectable users, but Ro is the stronger default recommendation.

Frequently Asked Questions

Read Our Full Reviews

Related Comparisons

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.